Haematological Disorders Mental and Behavioural Disorders Nervous System Diseases Nutritional, Metabolic, Endocrine Paediatrics
Conditions
Interventions
group c by liposomal iron
placebo
Sponsors
menoufia faculty of medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age range 6 months till 59 months old at baseline screenin c–reactive protein (CRP) is negative at the start and also in follow-up analysis, Hb concentration is 7.0 g/dl or above, and heart rate within normal range no history of consumption of iron supplements for 4 months ago or history of blood transfusion, if anemia is found, no other causes rather than ID are present, the child has no chronic or acute diseases (except for asthma) over the time of follow-up. no hemolytic anemia established diagnosed hemoglobinopathy (e.g., sickle cell disease, beta thalassemia major), or neurological disability as cerebral palsy, developmental delay or fits.
Exclusion criteria
Exclusion criteria: Children with a past history of prematurity, born small for date, or low birth weight below 2500 grams were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to assess whether liposomal iron plus diet advice is superior to diet advice alone in terms of neurodevelopmental outcomes in children aged 6-59 months identified with NAID following screening. | — |
Secondary
| Measure | Time frame |
|---|---|
| to assess laboratory and anthropometric outcomes after intervention on anemic and NAID children. | — |
Countries
Egypt
Contacts
Public Contactkerollos samaan
lecturer assisstant
Outcome results
None listed